INNATE PHARMA
Innate Pharma S.A. is a biopharmaceutical company developing first-in-class immunotherapy drug candidates for cancer and inflammatory diseases. The Company specializes in the development of novel monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity cells. Its innovative approaches have led to licensing agreements with Novo Nordisk A/S and Bristol-Myers Squibb.
INNATE PHARMA
Industry:
Biopharma Biotechnology Clinical Trials Medical Pharmaceutical
Founded:
1999-01-01
Address:
Marseille, Provence-Alpes-Cote D'Azur, France
Country:
France
Website Url:
http://www.innate-pharma.com
Total Employee:
51+
Status:
Active
Contact:
+33 (0)4 30 30 30 30
Total Funding:
201.1 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Tag Manager Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Advisor
Current Employees Featured
Mondher Mahjoubi Chief Executive Officer @ Innate Pharma
Chief Executive Officer
Joyson Karakunnel EVP, Chief Medical Officer @ Innate Pharma
EVP, Chief Medical Officer
2020-07-01
Alessandro Moretta Founder @ Innate Pharma
Founder
Marcel Rozencweig President @ Innate Pharma
President
2009-01-01
Ronak Savla Associate Director Medical Affairs @ Innate Pharma
Associate Director Medical Affairs
2021-03-01
Laure-Hélène Mercier Chief Financial Officer @ Innate Pharma
Chief Financial Officer
Eric Vivier Senior Vice President, Chief Scientific Officer @ Innate Pharma
Senior Vice President, Chief Scientific Officer
Marc Bonneville Founder @ Innate Pharma
Founder
Jennifer Butler Executive Vice President, US - General Manager @ Innate Pharma
Executive Vice President, US - General Manager
2019-05-01
Jean Fournie Founder @ Innate Pharma
Founder
Founder
Stock Details
Investors List
BNP Paribas
BNP Paribas investment in Post-IPO Debt - Innate Pharma
Societe Generale
Societe Generale investment in Post-IPO Debt - Innate Pharma
AstraZeneca
AstraZeneca investment in Corporate Round - Innate Pharma
QVT Financial
QVT Financial investment in Post-IPO Equity - Innate Pharma
Redmile Group
Redmile Group investment in Post-IPO Equity - Innate Pharma
Ardian
Ardian investment in Series C - Innate Pharma
Ace Capital Partners
Ace Capital Partners investment in Series C - Innate Pharma
NIF SMBC Ventures
NIF SMBC Ventures investment in Series C - Innate Pharma
Novo Nordisk
Novo Nordisk investment in Series C - Innate Pharma
Akka Venture
Akka Venture investment in Series C - Innate Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-16 | Innate Pharma announces the appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer |
Official Site Inspections
http://www.innate-pharma.com Semrush global rank: 1.64 M Semrush visits lastest month: 15.16 K
Unable to get host informations!!!
More informations about "Innate Pharma"
Innate Pharma - Crunchbase Company Profile & Funding
Innate Pharma S.A. is a biopharmaceutical company developing first-in-class immunotherapy drug candidates for cancer and inflammatory diseases. The …See details»
Company profile | Innate Pharma
117, Avenue de Luminy - BP 30191 13 009 Marseille FRANCE +33 (0)4 30 30 30 30 Innate Pharma, Inc. 2273 Research Boulevard, Suite 350 Rockville, MD 20850, USASee details»
Bienvenue chez Innate Pharma | Innate …
Innate Pharma Annonce Sa Participation A La 2025 Leerink Partners Global Healthcare Conference. 27 février 2025. Innate Pharma reçoit le statut de « Breakthrough Therapy » de la …See details»
Innate Pharma - Overview, News & Similar companies - ZoomInfo
Innate Pharma contact info: Phone number: +33 430303030 Website: www.innate-pharma.com What does Innate Pharma do? Founded in 1999, Innate Pharma S.A. is a commercial stage …See details»
Investor Relations | Innate Pharma
Feb 17, 2025 At Innate Pharma, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are …See details»
Organization | Innate Pharma
Innate FFAAP Medicines, L.L.C. | Innate Pharma | INNATE PHARMA | Innate Pharma, Inc. | Prothione, LLC Active Ingredients. Marketed Drugs (1) moxetumomab pasudotox (2018) …See details»
Investors - Governance - Corporate Governance | Innate Pharma
Innate Pharma seeks to follow best practice in corporate governance. The company set up a Scientific Advisory Board in 2000, a Compensation Committee in 2001 and an Audit …See details»
Innate Pharma - Contacts, Employees, Board Members
Innate Pharma has 13 current employee profiles, including Chief Executive Officer Mondher Mahjoubi. Innate Pharma has 1 board member or advisor, François Romagne. Contacts. Edit …See details»
Innate Pharma - Craft
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer …See details»
Innate Pharma Announces Conference Call and Webcast for Full …
4 days ago Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announces that the Company will hold a conference call on Thursday, March 27, 2025 …See details»
Welcome to Innate Pharma | Innate Pharma
Innate Pharma announces Nectin-4 antibody drug conjugate investor and analyst event in New York. January 21, 2025. Number of shares and voting rights of Innate Pharma as of December …See details»
Innate Pharma Appoints Jonathan Dickinson as CEO and Chairman …
Oct 14, 2024 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its supervisory Board has appointed Jonathan Dickinson as …See details»
Innate Pharma: Moving Into The Padcev Space - Seeking Alpha
3 days ago Innate Pharma's diverse pipeline, including lacutamab, IPH6501, and IPH4502, shows promising clinical activity and potential for significant milestones in 2025.See details»
COMPANY OVERVIEW - innate-pharma.com
(“AMF”),available on the AMF website (www.amf-france.org) or on the Company’s website (www.innate-pharma.com), and public filings and reports filed with the U.S. Securities and …See details»
Innate Pharma Announces U.S. FDA Granted Breakthrough …
Feb 17, 2025 Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research …See details»
Innate Pharma Announces Transformative Strategy to ... - BioSpace
Jan 10, 2025 About Innate Pharma Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to …See details»
Innate Pharma Announces Transformative Strategy to Accelerate …
Jan 10, 2025 Three Pillars of Growth. Drive innovation with first-in-class ANKET ® Platform: A new era in NK cell therapeutics is at the heart of Innate Pharma’s strategy, based around its …See details»
Innate Pharma Announces Transformative Strategy to Accelerate …
Jan 13, 2025 Innate Pharma's broad antibody portfolio includes several potential «first-in-class» candidates in clinical and preclinical stages in cancers with high medical need. Innate Pharma …See details»
Welcome to Innate Pharma | Innate Pharma
Nov 12, 2021 Innate Pharma to participate in the Evercore ISI 4th Annual Healthconx Virtual Conference. November 24, 2021. Innate Pharma Third Quarter 2021 Report. November 16, …See details»
Innate Pharma Announces Transformative Strategy to
Jan 10, 2025 Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research …See details»